查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678464

去识别健康资料市场规模、份额、趋势分析报告：按资料类型、应用、最终用途、地区和细分市场进行预测（2025-2030 年）

De-identified Health Data Market Size, Share & Trends Analysis Report By Type Of Data, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

去识别健康资料市场的成长和趋势：

根据Grand View Research, Inc.的最新报告，全球去识别健康资料市场规模预计将在2030年达到135.9亿美元，2025年至2030年期间的复合年增长率为9.07%。

该市场成长的主要驱动力是医疗保健领域对资料分析的需求不断增长，以支持人口健康研究和预测模型，同时确保患者的隐私。资料保护监管压力不断增加，加上人工智慧和机器学习的进步，对大型去识别资料集的需求日益增长。此外，穿戴式装置和电子健康记录(EHR)资料的激增产生了大量适合去识别和二次利用的信息，进一步推动了市场需求。

透过分析患者在药局和健康保险计划中的登记模式，这些去识别资料将被用来了解保险状况。这些资料使公司能够识别主要和次要付款人、评估保险趋势并了解患者的人口统计数据，同时又不损害隐私。例如，2024 年 6 月，科莫多健康宣布了科莫多患者保险（KPI）。这种新颖的资料产品提供了有关超过 2 亿美国患者的保险状况的详细资讯。此资源精确定位患者的药局和健康保险登记状况，并详细列出各个管道、部门和地区的主要和次要付款人资讯。 KPI 将帮助商业、市场准入、医疗事务和卫生经济、成果和研究 (HEOR) 团队有效解决与病患登记和付款人映射相关的关键业务问题。

此外，主要市场参与企业之间日益增长的合作与伙伴关係预计将推动市场成长。例如，2024 年 3 月，Verantos 宣布与 Curimeta 建立合作伙伴关係，以加强去识别化健康资料在临床研究中的使用。此次合作的重点是改善现实世界的证据生成，同时透过强大的资料去识别流程确保病患的隐私。透过利用 Curimeta 的资料科学能力和 Verantos 的真实资料专业知识，该伙伴关係旨在提供有价值的见解，推动医疗保健创新并改善患者治疗效果。关注去识别资料对于促进安全资料共用和遵守监管标准至关重要。

“Verantos 证据平台使用人工智慧 (AI) 来产生针对特定疾病的见解。至关重要的是，AI 模型要使用高质量的患者照护资料进行训练。CuriMeta 的加入将使用于加速生命科学研究的针对特定疾病的实用登记册得到增强。”

Verantos 总裁 Anand Shroff

去识别化健康资料市场报告重点

  • 根据资料类型，临床资料区段将在 2024 年占据市场主导地位，份额约为 17.0%。该部分的主导地位归因于其在研究、治疗开发和优化患者照护中的关键作用。
  • 根据应用，临床研究和临床试验部门在 2024 年占据了最大的收益占有率。这是因为它在推进治疗方法、医疗设备创新和病人安全方面发挥关键作用。
  • 根据最终用途，医疗保健提供者部门在 2024 年占据了最大的收益占有率。医疗保健提供者部门引领市场，因为他们在临床决策、优化治疗和改善患者结果方面发挥关键作用。
  • 2024 年，北美占据市场主导地位，营收份额为 31.53%。该地区拥有先进的医疗保健基础设施，并正在进行大量技术投资，尤其是在资料分析和人工智慧领域。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 去识别化健康资料市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
  • 去识别化健康资料市场分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • COVID-19 的影响

4. 去识别化健康资料市场：资料类型估计与趋势分析

  • 按资料类型分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球去识别健康资料市场展望（按资料类型）
  • 临床资料
  • 基因组资料
  • 患者人口统计
  • 处方资料
  • 索赔资料
  • 行为资料
  • 穿戴式装置和感测器资料
  • 调查和患者报告的资料
  • 影像资料
  • 检验资料
  • 医院和提供者资料
  • 健康社会决定因素 (SDoH)资料
  • 药物基因组学资料
  • 生物识别资料
  • 营运和财务资料
  • 流行病学资料
  • 医疗保健使用资料
  • 其他的

5. 去识别化健康资料市场：最终用途估计与趋势分析

  • 市场占有率（2024 年和 2030 年）：依最终用途划分
  • 细分仪表板
  • 全球去识别健康资料市场前景（依最终用途划分）
  • 製药公司
  • 生技公司
  • 医疗设备製造商
  • 医疗保健提供者
  • 保险公司/医疗付款人
  • 研究所
  • 政府
  • 其他的

第六章 去识别化健康资料市场：应用评估和趋势分析

  • 市场占有率（2024 年和 2030 年）：按应用划分
  • 细分仪表板
  • 全球去识别健康资料市场展望（按应用）
  • 临床研究和临床实验
  • 公共卫生
  • 精准医疗
  • 健康经济与成果研究（HEOR）
  • 人口健康管理
  • 药物研发
  • 提高医疗品质
  • 承保及风险评估
  • 市场进入和商业策略
  • 商业智慧和营运效率
  • 远端医疗和远端监控
  • 病人参与和支持计划
  • 其他的

7. 去识别化健康资料市场：区域估计和趋势分析、按资料类型、按最终用途和按应用

  • 区域市场占有率分析（2024 年和 2030 年）
  • 区域市场仪表板
  • 全球区域市场概述
  • 市场规模及预测趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 创新者
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业的市场占有率分析 - 2024 年
    • IQVIA
    • Oracle（Cerner Corporation）
    • Merative（Truven Health Analytics）
    • Optum, Inc.（UnitedHealth Group）
    • ICON plc
    • Veradigm LLC（Formerly known as Allscripts）
    • IBM
    • Flatiron Health（F. Hoffmann-La Roche Ltd）
    • Premier, Inc.
    • Shaip
    • Komodo Health, Inc.
    • Evidation Health, Inc.
    • Medidata
    • Clarify Health Solutions
    • Satori Cyber Ltd.
Product Code: GVR-4-68040-481-1

De-identified Health Data Market Growth & Trends:

The global de-identified health data market size is expected to reach USD 13.59 billion by 2030, registering a CAGR of 9.07% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market's growth is primarily driven by the rising demand for data analytics in healthcare, which supports population health studies and predictive modeling while ensuring patient privacy. Increasing regulatory pressure surrounding data protection, combined with AI and machine learning advancements, is creating a growing need for large-scale, de-identified datasets. In addition, the surge in data from wearables and electronic health records (EHRs) generates substantial volumes of information suitable for de-identification and secondary use, further boosting market demand.

De-identified data is utilized to derive insights into insurance status by analyzing patterns related to patient enrollment in pharmacy and medical insurance. This data enables organizations to identify primary and secondary payers, assess coverage trends, and understand patient demographics without compromising privacy. For instance, in June 2024, Komodo Health introduced the Komodo Patient Insurance (KPI). This novel data offering provides detailed insights into the insurance status of over 200 million de-identified U.S. patients. This resource accurately identifies patients' pharmacy and medical insurance enrollment, detailing primary and secondary payer information across various channels, segments, and geographies. The KPI will assist Commercial, Market Access, Medical Affairs, and Health Economics and Outcomes Research (HEOR) teams in efficiently addressing key business questions related to patient enrollment and payer mapping.

Moreover, the increasing partnership and collaboration among the key market players are expected to drive market growth. For instance, in March 2024, Verantos announced a partnership with Curimeta to enhance the utilization of de-identified health data in clinical research. This collaboration focuses on improving real-world evidence generation while ensuring patient privacy through robust data de-identification processes. By leveraging Curimeta's data science capabilities and Verantos' expertise in real-world data, the partnership aims to provide valuable insights that can drive healthcare innovations and improve patient outcomes. The emphasis on de-identified data is crucial for facilitating secure data sharing and compliance with regulatory standards.

"The Verantos Evidence Platform uses artificial intelligence (AI) to generate unique disease-specific insights. It is critical that AI models are trained using high-quality patient care data. CuriMeta's participation will enable us to enhance our disease-specific Pragmatic Registries that are used to accelerate life sciences research."

Anand Shroff, President of Verantos

De-identified Health Data Market Report Highlights:

  • Based on the type of data, the clinical data segment dominated the market with almost 17.0% of the share in 2024. The segment's dominance is attributed to its crucial role in research, treatment development, and patient care optimization.
  • Based on application, the clinical research and trials segment held the largest revenue share in 2024. This is attributed to its key role in advancing treatment methods, medical device innovation, and patient safety.
  • Based on the end-use, the healthcare providers segment held the largest revenue share in 2024. The healthcare providers segment leads the market owing to its crucial role in clinical decision-making, treatment optimization, and patient outcome improvement.
  • North America dominated the market with a revenue share of 31.53% in 2024. The region has an advanced healthcare infrastructure and significant technological investment, particularly in data analytics and AI.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type of data
    • 1.1.2. End use
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type of data outlook
    • 2.2.2. End use outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. De-identified Health Data Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market Opportunity analysis
  • 3.3. De-identified Health Data Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. COVID-19 Impact

Chapter 4. De-identified Health Data Market: Type of Data Estimates & Trend Analysis

  • 4.1. Type of Data Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global De-identified Health Data Market by Type of Data Outlook
  • 4.4. Clinical Data
    • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Genomic Data
    • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. Patient Demographics
    • 4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Prescription Data
    • 4.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Claims Data
    • 4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Behavioral Data
    • 4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Wearable and Sensor Data
    • 4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.11. Survey and Patient-Reported Data
    • 4.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.12. Imaging Data
    • 4.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.13. Laboratory Data
    • 4.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.14. Hospital and Provider Data
    • 4.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.15. Social Determinants of Health (SDoH) Data
    • 4.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.16. Pharmacogenomic Data
    • 4.16.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.17. Biometric Data
    • 4.17.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.18. Operational and Financial Data
    • 4.18.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.19. Epidemiological Data
    • 4.19.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.20. Healthcare Utilization Data
    • 4.20.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.21. Others
    • 4.21.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. De-identified Health Data Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global De-identified Health Data Market by End Use Outlook
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.5. Biotechnology Firms
    • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.6. Medical Device Manufacturers
    • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.7. Healthcare Providers
    • 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.8. Insurance Companies/ Healthcare Payers
    • 5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.9. Research Institutions
    • 5.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.10. Government Agencies
    • 5.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. De-identified Health Data Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global De-identified Health Data Market by Application Outlook
  • 6.4. Clinical Research and Trials
    • 6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.5. Public Health
    • 6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.6. Precision Medicine
    • 6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.7. Health Economics and Outcomes Research (HEOR)
    • 6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.8. Population Health Management
    • 6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.9. Drug Discovery and Development
    • 6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.10. Healthcare Quality Improvement
    • 6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.11. Insurance Underwriting and Risk Assessment
    • 6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.12. Market Access and Commercial Strategy
    • 6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.13. Business Intelligence and Operational Efficiency
    • 6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.14. Telemedicine and Remote Monitoring
    • 6.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.15. Patient Engagement and Support Programs
    • 6.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.16. Others
    • 6.16.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 7. De-identified Health Data Market: Regional Estimates & Trend Analysis, By Type of Data, By End use, By Application

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 - 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Innovators
  • 8.4. Vendor Landscape
    • 8.4.1. List of key distributors and channel partners
    • 8.4.2. Key customers
    • 8.4.3. Key company market share analysis, 2024
    • 8.4.4. IQVIA
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Oracle (Cerner Corporation)
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Merative (Truven Health Analytics)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Optum, Inc. (UnitedHealth Group)
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. ICON plc
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Veradigm LLC (Formerly known as Allscripts)
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. IBM
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology Type benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Flatiron Health (F. Hoffmann-La Roche Ltd)
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Technology Type benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Premier, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Technology Type benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Shaip
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Technology Type benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Komodo Health, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Technology Type benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Evidation Health, Inc.
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Technology Type benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Medidata
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Technology Type benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Clarify Health Solutions
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Technology Type benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Satori Cyber Ltd.
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Technology Type benchmarking
      • 8.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America de-identified health data market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 4 North America de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 7 U.S. de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 10 Canada de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 12 Mexico de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 13 Mexico de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Mexico de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe de-identified health data market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 17 Europe de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 19 Germany de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 20 Germany de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Germany de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 22 UK de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 23 UK de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 25 France de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 26 France de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 27 France de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 29 Italy de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Italy de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 32 Spain de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Spain de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 34 Denmark de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 35 Denmark de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Denmark de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 37 Sweden de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 38 Sweden de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Sweden de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 41 Norway de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Norway de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific de-identified health data market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 47 China de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 48 China de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 49 China de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 51 Japan de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 53 India de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 54 India de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 55 India de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Korea de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 57 South Korea de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 58 South Korea de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 60 Australia de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 62 Thailand de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 63 Thailand de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Thailand de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America de-identified health data market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 67 Latin America de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Latin America de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 70 Brazil de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Brazil de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 72 Argentina de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 73 Argentina de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Argentina de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 75 MEA de-identified health data market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 77 MEA de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 78 MEA de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 79 South Africa de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 80 South Africa de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 81 South Africa de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 85 UAE de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 86 UAE de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 87 UAE de-identified health data market, by application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait de-identified health data market, by type of data, 2018 - 2030 (USD Million)
  • Table 89 Kuwait de-identified health data market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Kuwait de-identified health data market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 De-identified Health Data market: market outlook
  • Fig. 9 De-identified Health Data competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 De-identified Health Data market driver impact
  • Fig. 15 De-identified Health Data market restraint impact
  • Fig. 16 De-identified Health Data market strategic initiatives analysis
  • Fig. 17 De-identified Health Data market: Type of Data movement analysis
  • Fig. 18 De-identified Health Data market: Type of Data outlook and key takeaways
  • Fig. 19 Clinical data market estimates and forecast, 2018 - 2030
  • Fig. 20 Genomic data market estimates and forecast, 2018 - 2030
  • Fig. 21 Patient demographics market estimates and forecast, 2018 - 2030
  • Fig. 22 Prescription data market estimates and forecast, 2018 - 2030
  • Fig. 23 Claims data market estimates and forecast, 2018 - 2030
  • Fig. 24 Behavioral data market estimates and forecast, 2018 - 2030
  • Fig. 25 Wearable and sensor data market estimates and forecast, 2018 - 2030
  • Fig. 26 Survey and patient-reported data market estimates and forecast, 2018 - 2030
  • Fig. 27 Imaging data market estimates and forecast, 2018 - 2030
  • Fig. 28 Laboratory data market estimates and forecast, 2018 - 2030
  • Fig. 29 Hospital and provider data market estimates and forecast, 2018 - 2030
  • Fig. 30 Social determinants of health (SDoH) data market estimates and forecast, 2018 - 2030
  • Fig. 31 Pharmacogenomic data market estimates and forecast, 2018 - 2030
  • Fig. 32 Biometric data market estimates and forecast, 2018 - 2030
  • Fig. 33 Operational and financial data market estimates and forecast, 2018 - 2030
  • Fig. 34 Epidemiological data market estimates and forecast, 2018 - 2030
  • Fig. 35 Healthcare utilization data market estimates and forecast, 2018 - 2030
  • Fig. 36 Others market estimates and forecast, 2018 - 2030
  • Fig. 37 De-identified Health Data market: End use analysis
  • Fig. 38 De-identified Health Data market: End use outlook and key takeaways
  • Fig. 39 Pharmaceutical companies market estimates and forecast, 2018 - 2030
  • Fig. 40 Biotechnology firms market estimates and forecast, 2018 - 2030
  • Fig. 41 Medical device manufacturers market estimates and forecast, 2018 - 2030
  • Fig. 42 Healthcare providers market estimates and forecast, 2018 - 2030
  • Fig. 43 Insurance companies/ Healthcare payers market estimates and forecast, 2018 - 2030
  • Fig. 44 Research institutions market estimates and forecast, 2018 - 2030
  • Fig. 45 Government agencies market estimates and forecast, 2018 - 2030
  • Fig. 46 Others market estimates and forecast, 2018 - 2030
  • Fig. 47 De-identified Health Data market: Application movement analysis
  • Fig. 48 De-identified Health Data market: Application outlook and key takeaways
  • Fig. 49 Clinical research and trials market estimates and forecast, 2018 - 2030
  • Fig. 50 Public health market estimates and forecast, 2018 - 2030
  • Fig. 51 Precision medicine market estimates and forecast, 2018 - 2030
  • Fig. 52 Health economics and outcomes research (HEOR) market estimates and forecast, 2018 - 2030
  • Fig. 53 Population health management market estimates and forecast, 2018 - 2030
  • Fig. 54 Drug discovery and development market estimates and forecast, 2018 - 2030
  • Fig. 55 Healthcare quality improvement market estimates and forecast, 2018 - 2030
  • Fig. 56 Insurance underwriting and risk assessment market estimates and forecast, 2018 - 2030
  • Fig. 57 Market access and commercial strategy market estimates and forecast, 2018 - 2030
  • Fig. 58 Business intelligence and operational efficiency market estimates and forecast, 2018 - 2030
  • Fig. 59 Telemedicine and remote monitoring market estimates and forecast, 2018 - 2030
  • Fig. 60 Patient engagement and support programs market estimates and forecast, 2018 - 2030
  • Fig. 61 Others market estimates and forecast, 2018 - 2030
  • Fig. 62 Global de-identified health data market: Regional movement analysis
  • Fig. 63 Global de-identified health data market: Regional outlook and key takeaways
  • Fig. 64 Global de-identified health data market share and leading players
  • Fig. 65 North America market share and leading players
  • Fig. 66 Europe market share and leading players
  • Fig. 67 Asia Pacific market share and leading players
  • Fig. 68 Latin America market share and leading players
  • Fig. 69 Middle East & Africa market share and leading players
  • Fig. 70 North America: SWOT
  • Fig. 71 Europe SWOT
  • Fig. 72 Asia Pacific SWOT
  • Fig. 73 Latin America SWOT
  • Fig. 74 MEA SWOT
  • Fig. 75 North America, by country
  • Fig. 76 North America
  • Fig. 77 North America market estimates and forecasts, 2018 - 2030
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 84 Europe
  • Fig. 85 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 86 UK key country dynamics
  • Fig. 87 UK market estimates and forecasts, 2018 - 2030
  • Fig. 88 Germany key country dynamics
  • Fig. 89 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 90 France key country dynamics
  • Fig. 91 France market estimates and forecasts, 2018 - 2030
  • Fig. 92 Italy key country dynamics
  • Fig. 93 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 94 Spain key country dynamics
  • Fig. 95 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 96 Denmark key country dynamics
  • Fig. 97 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 98 Sweden key country dynamics
  • Fig. 99 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 100 Norway key country dynamics
  • Fig. 101 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 102 Asia Pacific
  • Fig. 103 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 104 China key country dynamics
  • Fig. 105 China market estimates and forecasts, 2018 - 2030
  • Fig. 106 Japan key country dynamics
  • Fig. 107 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 108 India key country dynamics
  • Fig. 109 India market estimates and forecasts, 2018 - 2030
  • Fig. 110 Thailand key country dynamics
  • Fig. 111 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 112 South Korea key country dynamics
  • Fig. 113 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 114 Australia key country dynamics
  • Fig. 115 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 116 Latin America
  • Fig. 117 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 120 Argentina key country dynamics
  • Fig. 121 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 122 Middle East and Africa
  • Fig. 123 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 124 South Africa key country dynamics
  • Fig. 125 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 126 Saudi Arabia key country dynamics
  • Fig. 127 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 128 UAE key country dynamics
  • Fig. 129 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 130 Kuwait key country dynamics
  • Fig. 131 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 132 Market share of key market players- de-identified health data market